{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-062025","form_type":"8-K","ticker":null,"cik":"0001309057","company_name":"China Health Industries Holdings, Inc.","filed_at":"2024-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.526026+00:00","generated_at":"2026-05-31T20:09:45.072357+00:00","sec_items":["1.01","2.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"China Health sells subsidiary to Chairman Xin Sun for 594k shares and $6k cash","bullets":["On July 11, 2024, China Health closed the sale of 100% of Harbin Humankind Biology Technology to Chairman/CEO Xin Sun (99%) and his sister Liyuan Sun (1%).","Consideration: $594,000 paid via transfer of 594,000 shares of CHHE common stock (valued at $1.00/share) from Xin Sun; $6,000 cash from Liyuan Sun.","The subsidiary Humankind was previously wholly owned by China Health HK; its assets were transferred to another subsidiary (Hankang) prior to the sale.","This is a related-party transaction; no valuation or financial details of Humankind provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-062025","json":"https://secwatch.observer/filing/0001213900-24-062025.json","markdown":"https://secwatch.observer/filing/0001213900-24-062025.md","text":"https://secwatch.observer/filing/0001213900-24-062025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1309057/000121390024062025/0001213900-24-062025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1309057/000121390024062025/ea0209557-8k_china.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:09:45.072357+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fc6d70cac9862d399e4f4c33b11d3821db3afb91","claim":"China Health Industries Holdings, Inc. completed a disposition involving Mr. Xin Sun and Ms. Liyuan Sun for USD 600,000.","evidence_excerpt":"China Health HK agreed to transfer to Mr. Xin Sun 99% and Ms. Liyuan Sun 1% of the equity interests of Harbin Humankind Biology Technology Co., Limited. (“Humankind”), for a consideration of USD 594,000 and USD 6,000 respectively, totaling USD 600,000","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1309057/000121390024062025/0001213900-24-062025-index.htm","confidence":0.7,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Mr. Xin Sun and Ms. Liyuan Sun"},{"label":"Consideration","value":"USD 600,000"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}